BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29178884)

  • 1. A new panel of SNPs to assess thyroid carcinoma risk: a pilot study in a Brazilian admixture population.
    Dos Santos ICC; Genre J; Marques D; da Silva AMG; Dos Santos JC; de Araújo JNG; Duarte VHR; Carracedo A; Torres-Español M; Bastos G; de Oliveira Ramos CC; Luchessi AD; Silbiger VN
    BMC Med Genet; 2017 Nov; 18(1):140. PubMed ID: 29178884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
    Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mannose-binding lectin and MBL-associated serine protease-2 gene polymorphisms in a Brazilian population from Rio de Janeiro.
    Ferraroni NR; Segat L; Guimarães RL; Brandão LA; Crovella S; Constantino-Silva RN; Loja C; da Silva Duarte AJ; Grumach AS
    Int J Immunogenet; 2012 Feb; 39(1):32-8. PubMed ID: 22035380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 9q22.33 and 14q13.3 detects novel candidate functional SNPs in Europeans from metropolitan France and Melanesians from New Caledonia.
    Tcheandjieu C; Lesueur F; Sanchez M; Baron-Dubourdieu D; Guizard AV; Mulot C; Laurent-Puig P; Schvartz C; Truong T; Guenel P
    Int J Cancer; 2016 Aug; 139(3):617-27. PubMed ID: 26991144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma.
    Bonora E; Rizzato C; Diquigiovanni C; Oudot-Mellakh T; Campa D; Vargiolu M; Guedj M; ; McKay JD; Romeo G; Canzian F; Lesueur F
    Int J Cancer; 2014 May; 134(9):2098-107. PubMed ID: 24127282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common variants of the thyroglobulin gene are associated with differentiated thyroid cancer risk.
    Akdi A; Pérez G; Pastor S; Castell J; Biarnés J; Marcos R; Velázquez A
    Thyroid; 2011 May; 21(5):519-25. PubMed ID: 21476894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hTERT gene polymorphism correlates with the risk and the prognosis of thyroid cancer.
    Gong L; Xu Y; Hu YQ; Ding QJ; Yi CH; Huang W; Zhou M
    Cancer Biomark; 2016 Jul; 17(2):195-204. PubMed ID: 27472887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma.
    Pellé L; Cipollini M; Tremmel R; Romei C; Figlioli G; Gemignani F; Melaiu O; De Santi C; Barone E; Elisei R; Seiser E; Innocenti F; Zanger UM; Landi S
    Arch Toxicol; 2016 Dec; 90(12):3099-3109. PubMed ID: 26783003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WDR3 gene haplotype is associated with thyroid cancer risk in a Spanish population.
    Akdi A; Giménez EM; García-Quispes W; Pastor S; Castell J; Biarnés J; Marcos R; Velázquez A
    Thyroid; 2010 Jul; 20(7):803-9. PubMed ID: 20578902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations.
    Mancikova V; Cruz R; Inglada-Pérez L; Fernández-Rozadilla C; Landa I; Cameselle-Teijeiro J; Celeiro C; Pastor S; Velázquez A; Marcos R; Andía V; Álvarez-Escolá C; Meoro A; Schiavi F; Opocher G; Quintela I; Ansede-Bermejo J; Ruiz-Ponte C; Santisteban P; Robledo M; Carracedo A
    Int J Cancer; 2015 Oct; 137(8):1870-8. PubMed ID: 25855579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between interleukin 17/interleukin 17 receptor gene polymorphisms and papillary thyroid cancer in Korean population.
    Lee YC; Chung JH; Kim SK; Rhee SY; Chon S; Oh SJ; Hong IK; Eun YG
    Cytokine; 2015 Feb; 71(2):283-8. PubMed ID: 25484349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk.
    Figlioli G; Köhler A; Chen B; Elisei R; Romei C; Cipollini M; Cristaudo A; Bambi F; Paolicchi E; Hoffmann P; Herms S; Kalemba M; Kula D; Pastor S; Marcos R; Velázquez A; Jarząb B; Landi S; Hemminki K; Försti A; Gemignani F
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2084-92. PubMed ID: 25029422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant SNPs have limited prediction ability for thyroid cancer.
    Guo S; Wang YL; Li Y; Jin L; Xiong M; Ji QH; Wang J
    Cancer Med; 2014 Jun; 3(3):731-5. PubMed ID: 24591304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer.
    Santos LS; Gomes BC; Gouveia R; Silva SN; Azevedo AP; Camacho V; Manita I; Gil OM; Ferreira TC; Limbert E; Rueff J; Gaspar JF
    Oncol Rep; 2013 Nov; 30(5):2458-66. PubMed ID: 23982724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The common genetic variant rs944289 on chromosome 14q13.3 associates with risk of both malignant and benign thyroid tumors in the Japanese population.
    Rogounovitch TI; Bychkov A; Takahashi M; Mitsutake N; Nakashima M; Nikitski AV; Hayashi T; Hirokawa M; Ishigaki K; Shigematsu K; Bogdanova T; Matsuse M; Nishihara E; Minami S; Yamanouchi K; Ito M; Kawaguchi T; Kondo H; Takamura N; Ito Y; Miyauchi A; Matsuda F; Yamashita S; Saenko VA
    Thyroid; 2015 Mar; 25(3):333-40. PubMed ID: 25562676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor gene polymorphisms in thyroid cancer.
    Hsiao PJ; Lu MY; Chiang FY; Shin SJ; Tai YD; Juo SH
    J Endocrinol; 2007 Nov; 195(2):265-70. PubMed ID: 17951537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible Impact of RET Polymorphism and Its Haplotypic Association Modulates the Susceptibility to Thyroid Cancer.
    Khan MS; Pandith AA; Iqbal M; Naykoo NA; Khan SH; Rather TA; Mudassar S
    J Cell Biochem; 2015 Aug; 116(8):1712-8. PubMed ID: 25736215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of differentiated thyroid carcinoma and polymorphisms within the susceptibility cancer region 8q24.
    Cipollini M; Figlioli G; Garritano S; Bramante S; Maiorano L; Gnudi F; Cecchini A; De Paola F; Damicis L; Frixa T; Landi D; Cancemi L; De Santi C; Melaiu O; Foddis R; Cristaudo A; Bonotti A; Romei C; Elisei R; Pellegrini G; Barale R; Gemignani F; Landi S
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2121-5. PubMed ID: 24008490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single nucleotide polymorphism analysis in the human phosphatase PTPrj gene using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry.
    Powell N; Dudley E; Morishita M; Bogdanova T; Tronko M; Thomas G
    Rapid Commun Mass Spectrom; 2004; 18(19):2249-54. PubMed ID: 15384144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.